250 related articles for article (PubMed ID: 19404907)
1. [New therapeutic opportunities in metastatic renal cell carcinoma].
Buess M
Praxis (Bern 1994); 2009 Apr; 98(9):481-6. PubMed ID: 19404907
[TBL] [Abstract][Full Text] [Related]
2. Novel targeted therapy for advanced renal carcinoma: trials in progress.
Calabrò F; Sternberg CN
Curr Opin Urol; 2010 Sep; 20(5):382-7. PubMed ID: 20625300
[TBL] [Abstract][Full Text] [Related]
3. [Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].
Miller K; Bergmann L; Gschwend J; Keilholz U; Kuczyk M; Wirth M
Aktuelle Urol; 2013 Jan; 44(1):45-9. PubMed ID: 23015607
[TBL] [Abstract][Full Text] [Related]
4. Integration of surgery and systemic therapy for renal cell carcinoma.
Kenney PA; Wood CG
Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764
[TBL] [Abstract][Full Text] [Related]
5. ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease.
Patard JJ; Pignot G; Escudier B; Eisen T; Bex A; Sternberg C; Rini B; Roigas J; Choueiri T; Bukowski R; Motzer R; Kirkali Z; Mulders P; Bellmunt J
Eur Urol; 2011 Oct; 60(4):684-90. PubMed ID: 21704448
[TBL] [Abstract][Full Text] [Related]
6. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.
Lee Z; Jegede OA; Haas NB; Pins MR; Messing EM; Manola J; Wood CG; Kane CJ; Jewett MAS; Flaherty KT; Dutcher JP; DiPaola RS; Uzzo RG
J Urol; 2020 Apr; 203(4):684-689. PubMed ID: 31596672
[TBL] [Abstract][Full Text] [Related]
7. EORTC-GU group expert opinion on metastatic renal cell cancer.
de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
[TBL] [Abstract][Full Text] [Related]
8. Impact of anti-angiogenic treatments on metastatic renal cell carcinoma.
Ainsworth NL; Lee JS; Eisen T
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1793-805. PubMed ID: 19954291
[TBL] [Abstract][Full Text] [Related]
9. A survey of therapy for advanced renal cell carcinoma.
Basso M; Cassano A; Barone C
Urol Oncol; 2010; 28(2):121-33. PubMed ID: 19576800
[TBL] [Abstract][Full Text] [Related]
10. Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens.
Kusuda Y; Miyake H; Behnsawy HM; Fukuhara T; Inoue TA; Fujisawa M
Urol Oncol; 2013 Jan; 31(1):42-50. PubMed ID: 21396851
[TBL] [Abstract][Full Text] [Related]
11. New treatments for metastatic kidney cancer.
Mancuso A; Sternberg CN
Can J Urol; 2005 Feb; 12 Suppl 1():66-70; discussion 105. PubMed ID: 15780170
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy for high-risk renal cell carcinoma patients.
Kunkle DA; Haas NB; Uzzo RG
Curr Urol Rep; 2007 Jan; 8(1):19-30. PubMed ID: 17239313
[TBL] [Abstract][Full Text] [Related]
13. TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discovery.
Verzoni E; Ratta R; Grassi P; Salvioni R; Stagni S; Montone R; Fucà G; Cappelletti V; Reduzzi C; De Giorgi U; Procopio G
Tumori; 2018 Oct; 104(5):401-405. PubMed ID: 29192741
[TBL] [Abstract][Full Text] [Related]
14. Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?
Brookman-May S; May M; Gilfrich C; Wieland WF; Burger M
Expert Rev Anticancer Ther; 2010 Jun; 10(6):813-23. PubMed ID: 20553207
[TBL] [Abstract][Full Text] [Related]
15. Evolving role of novel targeted agents in renal cell carcinoma.
Hutson TE; Figlin RA
Oncology (Williston Park); 2007 Sep; 21(10):1175-80; discussion 1184, 1187, 1190. PubMed ID: 17926797
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and obstacles to combination targeted therapy in renal cell cancer.
Sosman JA; Puzanov I; Atkins MB
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):764s-769s. PubMed ID: 17255307
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for renal cell carcinoma.
Jacobsohn KM; Wood CG
Semin Oncol; 2006 Oct; 33(5):576-82. PubMed ID: 17045086
[TBL] [Abstract][Full Text] [Related]
18. [Systemic and surgical management of metastatic renal cell carcinoma].
Kramer MW; Merseburger AS; Peters I; Waalkes S; Kuczyk MA
Urologe A; 2012 Feb; 51(2):217-25. PubMed ID: 22009257
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy in renal cell carcinoma: is resection still solely enough?
Gharib KE
Future Oncol; 2021 Feb; 17(6):633-636. PubMed ID: 33305597
[No Abstract] [Full Text] [Related]
20. [Systemic therapy for metastatic renal cell carcinoma].
Kramer MW; Steffens S; von Klot C; Merseburger AS; Kuczyk MA
Aktuelle Urol; 2012 Jul; 43(4):265-8. PubMed ID: 22869498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
